California's Health in All Policies Task Force: Linking environmental sustainability with health and equity
California’s climate change leadership has presented the Task Force with many opportunities to promote health and equity through planning and decision-making related to the built environment including increasing active transportation and promoting dense urban infill. The Task Force has brought health and equity considerations into processes relating to dissemination of cap and trade proceeds, as well as embedded these goals into grant-making guidelines and scoring criteria for active transportation, affordable housing, community greening, and sustainable land use planning.
While the focus has largely been on the built environment, socioeconomic factors such as poverty, racism, and violence, play a tremendous role not only in shaping health outcomes for California’s population, but also in the state’s ability to achieve its climate change goals. The presenter will discuss how the Task Force has brought health and equity to bear on important land use decision-making processes, the many co-benefits the Task Force has identified of addressing both health and climate change, and some of the challenges that the Task Force – and California – face moving forward.
Learning Areas:Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Define the Health in All Policies concept of co-benefits. Describe the opportunities that climate change mitigation presents for promoting health equity. List at least three co-benefits between public health and other policy sectors
Qualified on the content I am responsible for because: I have served as the Program Director for the California Health in All Policies Task Force for the last three years. I have spoken locally, nationally, and internationally about this work as a subject matter expert.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.